Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its price target trimmed by BMO Capital Markets from $250.00 to $234.00 in a research note released on Tuesday morning, MarketBeat reports. The firm currently has an outperform rating on the biopharmaceutical company’s stock. A number of other analysts also recently weighed in on ALNY. Royal Bank of […]
Citigroup Lowers Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $233.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Cut to $218.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) in a research report report published on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. A number of other research analysts have also weighed in on ALNY. HC Wainwright reissued a buy rating and issued a $405.00 target price […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) had its price target lowered by equities research analysts at Morgan Stanley from $210.00 to $175.00 in a note issued to investors on Monday, FlyOnTheWall reports. Morgan Stanley’s target price would suggest a potential upside of 3.97% from the stock’s previous close. ALNY has been the subject of […]